DAY ONE BIOPHARMACEUTICALS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.69 USD | +3.45% |
|
+16.46% | +21.16% |
| 29/04 | North American Morning Briefing : Investors Brace -2- | DJ |
| 24/04 | Needham Adjusts Price Target on Day One Biopharmaceuticals to $33 From $30, Keeps Buy Rating | MT |
Chart calendar Day One Biopharmaceuticals, Inc.
6be56bce579fa00587f.stYu9WzJ1n2PAVdE-hjIcEGRSPAAuLLGSQAzhAOdTDU.4bsDwRaGsxPXRCMtyn-iH3necKp5juf3GC1B1zfZCXHT4XSHW6rjDL1HHg~462e4a1834e07a44802f205351a6cade
Upcoming events on Day One Biopharmaceuticals, Inc.
Past events on Day One Biopharmaceuticals, Inc.
| 24/04/2024 06:00 pm | OJEMDA™ FDA Approval Call |
| 05/03/2024 08:20 pm | TD Cowen Health Care Conference |
| 27/02/2024 03:00 am | Q4 2023 Earnings Release |
| 09/01/2024 12:00 am | JPMorgan Healthcare Conference |
| 28/11/2023 10:00 pm | Piper Sandler Healthcare Conference |
| 17/11/2023 11:55 pm | Society for Neuro Oncology Meeting - Abstract Number : CTNI-37 |
| 17/11/2023 11:45 pm | Society for Neuro Oncology Meeting - Abstract Number : CTNI-24 |
| 07/11/2023 03:00 am | Q3 2023 Earnings Release |
| 11/09/2023 | Morgan Stanley Global Healthcare Conference |
| 08/08/2023 | Wedbush PacGrow Healthcare Conference |
| 08/08/2023 02:00 am | Q2 2023 Earnings Release |
| 23/06/2023 | Society for Neuro-Oncology Biennial Pediatric Neuro-Oncology Research Conference |
| 22/06/2023 09:30 pm | Annual General Meeting |
| 14/06/2023 11:50 pm | Goldman Sachs Global Healthcare Conference |
| 05/06/2023 11:45 pm | American Society of Clinical Oncology Conference - Abstract Number: 10038 |
| 05/06/2023 11:45 pm | American Society of Clinical Oncology Conference - Abstract Number: TPS10067 |
| 05/06/2023 04:30 am | American Society of Clinical Oncology Conference |
| 04/06/2023 08:15 pm | American Society of Clinical Oncology Conference - Abstract Number: 10004 |
| 10/05/2023 | American Society of Pediatric Oncology/Hematology Conference |
| 01/05/2023 06:30 pm | Q1 2023 Earnings Release |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 13,3 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -72,5 -71,0 -2.23% | -147 -147 -0.15% | -206 -201 -2.25% | -252 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -72,7 -72,3 -0.55% | -147 -146 -0.83% | -206 -201 -2.66% | -242 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -72,8 -70,8 -2.73% | -142 -141 -0.58% | -189 -182 -4.08% | -227 |
|
Net income Million USD | Released Forecast Spread | -40,5 | -171 -136 -25.68% | -142 -143 0.54% | -189 -186 -1.58% | -228 |
|
EPS USD | Released Forecast Spread | -17,0 | -4,62 -3,77 -22.62% | -2,17 -2,18 0.52% | -2,37 -2,31 -2.45% | -2,62 |
| Announcement Date | 04/05/21 | 07/03/22 | 06/03/23 | 26/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,89 | 4,41 | 8,68 | 19,7 |
|
EBITDA Million USD | Released Forecast Spread | -21,9 -20,0 -9.62% | -27,7 -24,0 -15.59% | -36,7 -30,0 -22.38% | -39,7 -41,0 3.26% | -42,7 -41,4 -3.22% | -51,4 -50,0 -2.85% | ||||||||
|
EBIT Million USD | Released Forecast Spread | -22,0 -21,5 -2.11% | -27,7 -25,3 -9.53% | -36,7 -30,0 -22.4% | -39,7 -37,5 -5.81% | -42,7 -41,6 -2.87% | -45,9 -45,3 -1.22% | -49,3 -47,7 -3.16% | -51,4 -50,6 -1.73% | -59,5 -54,2 -9.84% | -59,8 | -63,6 | -59,8 | -58,3 | -47,3 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -21,9 -19,9 -10% | -27,7 -25,9 -7.13% | -36,5 -29,9 -22.04% | -37,8 -37,1 -1.77% | -40,1 -39,6 -1.23% | -42,4 -41,6 -1.82% | -45,9 -44,0 -4.25% | -46,2 -47,4 2.74% | -54,5 -49,0 -11.25% | -57,3 | -59,5 | -56,0 | -53,3 | -45,6 |
|
Net income Million USD | Released Forecast Spread | -21,9 -19,9 -10% | -27,7 -25,9 -7.13% | -36,5 -29,9 -22.04% | -37,8 -37,4 -1.09% | -40,1 -40,6 1.3% | -42,4 -42,6 0.5% | -45,9 -45,3 -1.23% | -46,2 -48,3 4.46% | -54,5 -49,9 -9.18% | -57,2 | -59,3 | -56,9 | -54,8 | -45,6 |
|
EPS USD | Released Forecast Spread | -0,35 -0,34 -5.1% | -0,48 -0,40 -18.93% | -0,60 -0,49 -22.85% | -0,53 -0,53 0.61% | -0,56 -0,57 1.32% | -0,59 -0,59 -0.49% | -0,61 -0,61 -0.76% | -0,54 -0,60 10.31% | -0,64 -0,58 -10.54% | -0,66 | -0,67 | -0,64 | -0,63 | -0,49 |
| Announcement Date | 07/03/22 | 12/05/22 | 04/08/22 | 07/11/22 | 06/03/23 | 01/05/23 | 07/08/23 | 06/11/23 | 26/02/24 | - | - | - | - | - |
| Today 04:00 pm | MODERNA, INC.: Q1 2024 Earnings Release |
| Today 04:30 pm | BLUEPRINT MEDICINES CORPORATION: Q1 2024 Earnings Release |
| Today 04:30 pm | KYMERA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| Today 04:30 pm | IQVIA HOLDINGS INC.: Q1 2024 Earnings Release |
| Today 05:30 pm | ALNYLAM PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 06/05/2024 | REVOLUTION MEDICINES, INC.: Q1 2024 Earnings Release (Projected) |
| 06/05/2024 | SYNDAX PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
| 07/05/2024 | FORTREA HOLDINGS INC.: Q1 2024 Earnings Release |
| 07/05/2024 | VERVE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 07/05/2024 | OLEMA PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
Past sector events for Day One Biopharmaceuticals, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- DAWN Stock
- Calendar Day One Biopharmaceuticals, Inc.
